| Lucy Johnston Perkins, PA-C | |
|
620 20th St South, H623 New Hillman Building, Birmingham, AL 35233 | |
| (205) 975-4850 | |
| Not Available |
| Full Name | Lucy Johnston Perkins |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 620 20th St South, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164902268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 1400 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
A new study has shown that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel). The study showed that the NOL monitor is able to detect the effect of dexmedetomidine on the patient's pain response and enable administration of less intraoperative opioids.
This is a sad day for millions of homebound and chronically ill older Americans and their loved ones. The Centers for Medicare & Medicaid Services decision to enforce regulations that require physicians to have face-to-face encounters with homebound patients to receive Medicare benefits is a mistake. These regulations were originally delayed due to serious concerns about physicians' readiness to comply with them and the drastic impact that it will have on seriously ill patients.
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Less than one per cent of healthy urban children surveyed in Toronto had received dental care by the recommended age of 12 months and less than two per cent had seen a dentist by the age of 24 months.
Improved understanding of the role of female sex hormones on the drivers and symptoms of premenstrual dysphoric disorder (PMDD) may shed light on the complex interactions between sex hormones and mood, potentially helping to explain the increased prevalence of mood disorders in women.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lucy Johnston Perkins, PA-C 620 20th St S, Birmingham, AL 35233-2010 Ph: () - | Lucy Johnston Perkins, PA-C 620 20th St South, H623 New Hillman Building, Birmingham, AL 35233 Ph: (205) 975-4850 |
News Archive
A new study has shown that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel). The study showed that the NOL monitor is able to detect the effect of dexmedetomidine on the patient's pain response and enable administration of less intraoperative opioids.
This is a sad day for millions of homebound and chronically ill older Americans and their loved ones. The Centers for Medicare & Medicaid Services decision to enforce regulations that require physicians to have face-to-face encounters with homebound patients to receive Medicare benefits is a mistake. These regulations were originally delayed due to serious concerns about physicians' readiness to comply with them and the drastic impact that it will have on seriously ill patients.
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Less than one per cent of healthy urban children surveyed in Toronto had received dental care by the recommended age of 12 months and less than two per cent had seen a dentist by the age of 24 months.
Improved understanding of the role of female sex hormones on the drivers and symptoms of premenstrual dysphoric disorder (PMDD) may shed light on the complex interactions between sex hormones and mood, potentially helping to explain the increased prevalence of mood disorders in women.
› Verified 5 days ago
Samuel Gilbert Sellers, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-228-7600 Fax: 208-228-7601 | |
Mrs. Rachel Elizabeth Lemaitre, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 52 Medical Park Dr E Ste 220, Birmingham, AL 35235 Phone: 205-838-4747 | |
Kathryn Elise Chappell Mahaffey, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1802 6th Ave S, Birmingham, AL 35233 Phone: 205-934-3411 | |
Dana Diesi Craft, Physician Assistant Medicare: Medicare Enrolled Practice Location: 701 19th St S # 112, Birmingham, AL 35233 Phone: 337-316-9823 | |
John Pellerin, Physician Assistant Medicare: Medicare Enrolled Practice Location: 833 Saint Vincents Dr Ste 403, Birmingham, AL 35205 Phone: 205-939-0447 | |
Gregory Howard Houston, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 510, Birmingham, AL 35243 Phone: 205-971-1750 Fax: 205-971-1751 | |
Caroline Jackson Hilliard, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-2240 |